Reports
Reports
Sale
The North America bone cement market was valued at USD 349.02 million in 2023, driven by the increasing number of joint replacement surgeries and rising advancements in bone cement formulations in the region. The market is expected to grow at a CAGR of 5.80% during the forecast period of 2024-2032, reaching a value of USD 580.57 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Bone cement is a biomaterial created by mixing a liquid phase and a powder phase which is then formed into a plastic paste. It has the ability to self-set after it has been implanted within the body. It is used in various trauma and orthopedic surgeries for implant fixation, primarily for the fixation of joint prostheses. Bone cement has been used for anchoring artificial joints such as shoulder, hip, elbow, and knee joints.
The North America bone cement market demand is driven by the growing aging population which is at a higher risk of developing osteoarthritis and other degenerative bone diseases. This increases the demand for joint replacement surgeries that often require the use of bone cement. Moreover, older adults are more susceptible to fractures which frequently need a surgical intervention that relies on bone cement for stabilization and healing. Improved diagnostic capabilities for bone diseases and heightened public awareness significantly aid to the expansion of the global bone cement market. Other factors that shape the market dynamics include the rising development of new formulations such as antibiotic-loaded bone cement and bioactive cement, the increasing incidence of sports injuries, and the expansion of specialized orthopedic centers.
Increased Regulatory Approvals to Affect the Market Landscape Significantly
In April 2024, United States-based orthopedic company OsteoRemedies® LLC received the U.S. Food and Drug Administration (FDA) approval for expanded indications of its dual antibiotic bone cement containing vancomycin and gentamicin called SPECTRUM® GV Bone Cement. The expanded indication that was granted FDA clearance includes the fixation of revision hip arthroplasty components. OsteoRemedies' SPECTRUM® GV Bone Cement is known to prevent bacterial adhesion of susceptible organisms, methicillin-resistant staphylococcal infections, and intermediate-resistant. The growth in such regulatory approvals is expected to influence market adoption and trust in advanced bone cement products, which is poised to impact the market dynamics.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Key Trends | Impact |
Shift Towards Minimally Invasive Surgical Techniques | The rising preference for minimally invasive techniques such as vertebroplasty and kyphoplasty to treat vertebral compression fractures is a major trend aiding the market growth. These procedures rely heavily on bone cement and thereby augment market demand. |
Increased Volume of Arthroplasty Procedures | The increasing prevalence of joint diseases like osteoarthritis and rheumatoid arthritis is resulting in a higher number of arthroplasty procedures. This amplifies the market demand. The procedure requires bone cement and is used for the restoration or realignment of joints to facilitate normal functioning. |
Advancements in Bone Cement Formulations | The North America bone cement market share is influenced by the rising innovations in bone cement formulations such as the development of antibiotic-loaded bone cement which helps in reducing the risk of post-surgical infections. In addition, bioactive bone cements that promote bone growth and osseointegration are experiencing significant market demand. |
Rising Cases of Osteoporosis | There are rising cases of osteoporosis globally which is characterised by deterioration of bone tissue and low bone density. This is also increasing the risk of fracture among osteoporosis-affected individuals, which bolsters the demand for bone cement in healthcare settings. |
North America Bone Cement Market Segmentation
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Market Breakup by Country
Polymethyl Methacrylate (PMMA) Cement Segment Expected to Lead the Market Share
Based on the product, the market can be divided into calcium phosphate cement (CPC), glass polyalkenoate cement, and polymethyl methacrylate (PMMA) cement. Polymethyl methacrylate (PMMA) cement accounts for a large share of the market because of its brilliant mechanical properties. It also has minimal toxicity and inert properties which make it suitable for hip-joint transplants. It is further expanding in the market because of its extensive use in various orthopedic procedures such as kyphoplasty, vertebroplasty, and arthroplasty.
Calcium phosphate cement (CPC) is biocompatible and expected to witness substantial North America bone cement market growth, owing to its properties such as moldability and injectability. However, they are primarily used in maxillo-facial and cranial surgeries due to the low level of mechanical strength of CPC. Research and development activities are focused on enhancing the microporosity in order to improve the degradation level.
Market Segmentation Based on Application Areas is Anticipated to Witness Substantial Growth
By application, the bone cement market in North America is segmented into kyphoplasty, arthroplasty, and vertebroplasty. Arthroplasty has held a leading share of the North America market and is expected to continue holding a larger market share. It is used in situations where medical treatments don’t prove to be effective in relieving pain and restoring the functioning of a joint. They are believed to be great alternatives and are thus gaining popularity among patients and doctors.
Kyphoplasty is a new technique in the North America bone cement market which is developed in order to treat pain caused by vertebral body compression fractures. It is also capable of restoring the height of damaged vertebrae. Its effectiveness is under debate, however, improvements in technique may improve the market share of kyphoplasty in coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the region, the market is segmented into the United States and Canada. The United States dominates the market share due to the increasing number of orthopedic surgeries, the growing aging population, and the rising advancements in bone cement formulations and application techniques. The presence of a well-established healthcare infrastructure and the key market players in the region also propels the market growth.
In Canada, the bone cement market is steadily growing driven by intensive research and development activities and increased healthcare initiatives and fundings for advanced medical treatments.
The key features of the market report comprise the patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Johnson & Johnson MedTech (Depuy Synthes)
Johnson & Johnson MedTech (Depuy Synthes) is a medical equipment manufacturing company that designs, manufactures, and distributes medical supplies and devices including bone cement products. They provide MedTech solutions, orthopaedic solutions, and also offers innovative and connected care to patients globally. It is headquartered in Massachusetts, United States, and was founded in 1895.
Stryker Corporation
Stryker Corporation was established in 1941 and is headquartered in Michigan, United States. It is a medication company that manufactures medical devices and equipment in order to make healthcare better and improve patient and hospital outcomes. It mainly offers products for neurotechnology, surgery, and orthopedics. Its hydroxyapatite bone cements are used widely for cranial applications.
Zimmer Biomet Holdings, Inc
Zimmer Biomet Holdings, Inc., founded in 1927 and based in Indiana, significantly contributes to the North America bone cement market share. The company is focused on the effective designing, manufacturing, and marketing of devices that will be helpful for orthopedic clinicians and surgeons in improving the quality of life of patients. It sells a broad range of orthopedic products, including bone cement.
Smith & Nephew plc
Leading medical equipment manufacturing company Smith & Nephew plc, also known as Smith+Nephew has a prominent presence in the market. It offers a strong portfolio focused on the regeneration, repair, and replacement of hard and soft tissue. The company focuses on biocompatibility and safety in their bone cement formulations to reduce the risk of adverse reactions.
Other key players in the market include Medtronic plc, DJO, LLC, Globus Medical, Inc., Arthrex, Inc., Cardinal Health, Inc., and Heraeus Medical LLC.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Bone Cement Market Overview
3.1 Global Bone Cement Market
3.1.1 Global Bone Cement Market Historical Value (2017-2023)
3.1.2 Global Bone Cement Market Forecast Value (2024-2032)
3.2 North America Bone Cement Market
3.2.1 North America Bone Cement Market Historical Value (2017-2023)
3.2.2 North America Bone Cement Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 North America Bone Cement Market Landscape*
5.1 North America Bone Cement: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Country
5.2 North America Bone Cement: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Application
6 North America Bone Cement Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 North America Bone Cement Market Segmentation (2017-2032)
7.1 North America Bone Cement Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Calcium Phosphate Cement (CPC)
7.1.3 Glass Polyalkenoate Cement
7.1.4 Polymethyl Methacrylate (PMMA) Cement
7.2 North America Bone Cement Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Kyphoplasty
7.2.3 Arthroplasty
7.2.4 Vertebroplasty
7.3 North America Bone Cement Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospital
7.3.3 Ambulatory Surgical Centres
7.3.4 Clinics
7.4 North America Bone Cement Market (2017-2032) by Country
7.4.1 Market Overview
7.4.2 United States
7.4.3 Canada
8 United States Bone Cement Market Segmentation (2017-2032)
8.1 United State Bone Cement Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Calcium Phosphate Cement (CPC)
8.1.3 Glass Polyalkenoate Cement
8.1.4 Polymethyl Methacrylate (PMMA) Cement
8.2 United State Bone Cement Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Kyphoplasty
8.2.3 Arthroplasty
8.2.4 Vertebroplasty
8.3 United State Bone Cement Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospital
8.3.3 Ambulatory Surgical Centres
8.3.4 Clinics
9 Canada Bone Cement Market Segmentation (2017-2032)
9.1 Canada Bone Cement Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Calcium Phosphate Cement (CPC)
9.1.3 Glass Polyalkenoate Cement
9.1.4 Polymethyl Methacrylate (PMMA) Cement
9.2 Canada Bone Cement Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Kyphoplasty
9.2.3 Arthroplasty
9.2.4 Vertebroplasty
9.3 Canada Bone Cement Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospital
9.3.3 Ambulatory Surgical Centres
9.3.4 Clinics
10 Regulatory Framework
10.1 Regulatory Overview
10.2 US FDA
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication Year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Strategic Initiative
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share Analysis, By Region (Top 5 Companies)
14.1.1 Market Share Analysis: North America
14.2 Johnson & Johnson MedTech (Depuy Synthes)
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 Stryker Corporation
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Zimmer Biomet Holdings, Inc
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Smith & Nephew plc
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 Medtronic plc
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 DJO, LLC
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Globus Medical, Inc.
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 Arthrex, Inc.
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Cardinal Health, Inc.
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic Reach and Achievements
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Heraeus Medical LLC
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 North America Bone Cement Market – Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom request.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.